Perspectives: Anticoagulation Management

Sarah A. Spinler

Sarah A. Spinler

PharmD, FCCP, FAHA, FASHP, FCPP, AACC, BCPS (AQ Cardiology)

  • Professor of Clinical Pharmacy
  • Department of Pharmacy Practice and Pharmacy Administration
  • Philadelphia College of Pharmacy
  • University of the Sciences in Philadelphia
  • Philadelphia, Pennsylvania

Using risk assessment tools to optimize anticoagulation therapy

I think it would be great to have a more balanced approach to risk assessment.

So for example, looking at both the risk of stroke and the risk of bleeding, maybe we should combine these assessments. I think if you're trying to make it simple across the board for all anticoagulants, you should use common patient-risk factors such as age, prior history of a bleeding episode, or kidney disease.

There are some common risk factors that would apply to all agents, but as far as individual agents, I don’t think we currently have that tool, so it’s hard to create an individual risk-benefit strategy based on some kind of score or scale, and apply it to an individual agent at this time.

About the Coagulation Center

The Coagulation Center is an educational resource for healthcare professionals. Guided by a global editorial board of experts, the Coagulation Center offers a range of clinical perspectives on balancing the benefit and risk of anticoagulation in a rapidly changing landscape. Within the Coagulation Center you will find roundtable discussions on anticoagulation management, materials for patient management including patient case studies, tools to help evaluate bleeding risk and stroke risk, and downloadable resources for your practice.